PhnyX Lab Secures $4 Million in Seed Funding Led by SK Networks
PhnyX Lab has successfully closed a $4 million seed funding round, announced in a press release. The round was led by SK Networks, with participation from prominent angel investors including Aidan Gomez, co-founder and CEO of Cohere, and Illia Polosukhin, co-founder of NEAR Protocol.
The funding will support the expansion of PhnyX Lab's flagship platform, Cheiron, which launched in December 2024. Cheiron is already utilized by over 60 companies, including Korea's top 10 pharmaceutical firms, to streamline complex workflows such as research paper and clinical trial searches. Building on this momentum, PhnyX Lab is expanding Cheiron into a broader product suite, including Cheiron Write, designed to automate medical writing processes.
This investment marks a significant milestone for PhnyX Lab as it aims to transform manual pharmaceutical processes into intelligent, integrated workflows, enhancing efficiency in drug discovery and approval processes.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Funding
More from: Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read more